Oncology Models

  • Free
  • Published date: October 16, 2025
    • Shirley, New York, United States

Creative Bioarray offers a broad range of well-characterized xenograft, patient-derived xenograft (PDX), syngeneic tumor models as well as genetically engineered mouse models (GEMMs). Combining these models with appropriate biomarkers, including flow cytometry and imaging, our portfolio allows our partners to select the most appropriate study design and screening method to identify promising compounds and optimize lead candidates.

https://dda.creative-bioarray.com/oncology-models.html

Result 0 votes
Hannah Cole
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • GMP Human EGF

    GMP Human EGF

    Immunology New York (New York) October 13, 2025 1.00 Dollar US$

    EGF; epidermal growth factor; epidermal growth factor (beta urogastrone); pro-epidermal growth factor; beta-urogastrone; URG; HOMG4 https://cell.creative-bioarray.com/p/3859/gmp-human-egf/

  • EFO-21

    EFO-21

    Immunology New York (New York) October 13, 2025 1.00 Dollar US$

    EFO-21 Established from the ascitic fluid of a 56-year-old Caucasian woman with dedifferentiated serous cystadenocarcinoma of the ovary in 1979 https://www.creative-bioarray.com/EFO-21-CSC-C0341-item-1151.htm

  • Acute Myeloid Leukemia (AML) BMMC FFPE Pellet

    Acute Myeloid Leukemia (AML) BMMC FFPE Pellet

    Immunology Shirley (New York) September 9, 2025 1.00 Dollar US$

    Applications Cancer Research Storage Ambient Temperature Species Human Sample Condition Cancer https://www.histobiolab.com/acute-myeloid-leukemia-aml-bmmc-ffpe-pellet-hff2-item-367.html